pur003
Small moleculeexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2009 (NCT00947687)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pur003
- pur003
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00989521 | Phase 1 | Dec 1, 2009 | McMaster University, Pulmatrix Inc., University of Western Ontario |
| NCT00947687 | Phase 1 | Jul 1, 2009 | hVIVO Services Limited, IQVIA, Pulmatrix Inc., University of London |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pulmatrix Inc. | For profit | 2 | 2 | 1 | 2009 |
| hVIVO Services Limited | For profit | 1 | 0 | 1 | 2009 |
| IQVIA | For profit | 1 | 0 | 1 | 2009 |
| McMaster University | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of Western Ontario | Academic/Hospital | 1 | 0 | 1 | 2009 |
6 organizations
Page 1 / 1